Skip to content
Lower risk Drug recall · FDA · Published January 21, 2025

Major Pharmaceuticals Lorazepam Tablets Recall: Failed Impurities and Sub-potent Drug Risk

Major Pharmaceuticals recalls Lorazepam 0.5mg tablets due to failed impurities and sub-potent drug results from stability testing. These tablets may not contain the correct amount of active ingredient. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0226-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling Lorazepam 0.5mg tablets that failed stability testing, meaning they might not contain the correct amount of active ingredient. This could lead to ineffective treatment if used as prescribed. Read more at govinfonow.com/recall/32325-major-pharmaceuticals-lorazepam-tablets-recall-failed-impurities-and-sub-potent.

Source Summary by GovInfoNow · govinfonow.com/recall/32325-major-pharmaceuticals-lorazepam-tablets-recall-failed-impurities-and-sub-potent · Updated August 17, 2026 · FDA enforcement record: FDA #D-0226-2025

Cite this page

“Major Pharmaceuticals Lorazepam Tablets Recall: Failed Impurities and Sub-potent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32325-major-pharmaceuticals-lorazepam-tablets-recall-failed-impurities-and-sub-potent. Based on FDA recall #D-0226-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0226-2025%22&limit=1).

The FDA announced on Jan. 21, 2025, that Major Pharmaceuticals is recalling Lorazepam Tablets, USP, 0.5mg due to failed impurity specifications and sub-potent drug results. The agency stated the recall is voluntary and ongoing.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Lorazepam Tablets, USP, 0.5mg, Unit Dose
  • Packaging: 100 tablets per carton (10 x 10 blister packs)
  • NDC: 0904-6007-61
  • Lot codes: N01424, N01425, N01659, N01660, N01668, N01679, N01704, N01745, N01856, N01973, N02079
  • Expiration dates: 03/31/2025, 08/31/2025, 09/2025, 10/31/2025, 02/28/2026, 05/31/2026, 08/31/2026
  • Quantity: 82,281 cartons
  • Distribution: Nationwide U.S. and Puerto Rico

The hazard

According to the FDA, out-of-specification results were obtained during routine stability testing for Assay and Impurities. The drug product contained failed impurities/degradation specifications and was sub-potent.

Context

GovInfoNow's records show that Major Pharmaceuticals has had 14 other recalls on record since May 31, 2023. Other recent recalls of similar products include Major Chlorpromazine 50mg Tablets Recall (Sept. 12, 2025), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (Sept. 2, 2025), and Major Pharmaceuticals Carvedilol Tablets Recall (Aug. 20, 2025). Other recent recalls of similar products include Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026).

How to tell if you have this one

Check for the product name 'Lorazepam Tablets, USP, 0.5mg, Unit Dose' in 100 tablets per carton (10 x 10 blister packs). The lot numbers and expiration dates listed in the recall notice indicate specific batches.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide U.S. and Puerto rico
  • NDC
    0904-6007-60, 0904-6007-61, 0904-6008-60, 0904-6008-61, 0904-6009-60, 0904-6009-61
Recall numberProduct, codes & lotsQuantity
D-0226-2025Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61; Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026.82,281 cartons
D-0227-2025Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-905 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6008-61.; Lot #s: N01419, N01420, N01421, Exp 03/31/2025; N01663, Exp 06/30/2025; N01664, Exp 08/31/2025; N01673, Exp 09/30/2025; N01688, Exp 08/31/2025; N01747, N01748, N01749, Exp 11/30/2025; N01792, Exp 12/31/2025; N01857, Exp 02/28/2026; N01974, Exp 05/31/2026; N02081, Exp 08/31/2026.94,349 cartons
D-0228-2025Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-906 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6009-61.; Lot #s: N01422, N01423, Exp 03/31/2025; N01661, N01662, Exp 09/30/2025; N01746, N01750, Exp 10/31/2025; N01876, N01877, Exp 03/31/2026; N01899, N01900, N01975, Exp 04/30/2026.27,525 cartons
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Major Pharmaceuticals for specific instructions on how to handle the recalled tablets.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide U.S. and Puerto rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 36 days after the firm started it.

1. Firm started the recall: Jan 21, 202512. FDA classified it Class II: Feb 19, 202523. Published in FDA’s Enforcement Report: Feb 26, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Are there any safety risks from using these tablets?

The recall indicates a potential risk of ineffective treatment if used as prescribed, but no immediate safety hazards are reported.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0226-2025 (January 21, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0226-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA